Home/SanegeneBio/Shiyu Wang, Ph.D.

SW

Shiyu Wang, Ph.D.

Co-Founder, Chief Scientific Officer

Therapeutic Areas

Metabolic Diseases Obesity Autoimmune Diseases Cardiovascular Diseases

SanegeneBio Pipeline

Drug	Indication	Phase
Undisclosed (Obesity/Metabolic)	Obesity/Metabolic Disorders	Phase 2
Undisclosed (Complement)	Complement-Mediated Immune Disease	Phase 1
Undisclosed (Cardiometabolic)	Cardiometabolic Disease	Phase 1

Leadership Team at SanegeneBio

Weimin Wang, Ph.D.

Founder, Chief Executive Officer

Marc Abrams, Ph.D.

Chief Technology Officer and Head of US Operations

Yuyan Jin, Ph.D.

Senior Vice President of Clinical and Non-Clinical Development

View full SanegeneBio profile